Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea
Szajewska H, Kolodziej M
Published in Alimentary Pharmacology & Therapeutics
Key Findings
Saccharomyces boulardii reduced the risk of antibiotic-associated diarrhoea from about 19 percent to 8.5 percent across 21 randomised trials in children and adults.
Conclusions
S. boulardii is effective for preventing antibiotic-associated diarrhoea.
Limitations
Trial quality varied; dose and duration heterogeneity.
Supplements Studied
Saccharomyces boulardii reduced the risk of antibiotic-associated diarrhoea from about 19 percent to 8.5 percent across 21 randomised trials in children and adults.
Outcomes Measured
S. boulardii reduced the risk of antibiotic-associated diarrhoea from about 19 percent to 8.5 percent.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.